The history of Viagra presents a interesting case for stakeholders in the pharmaceutical sector. While initially a blockbuster success, producing huge profits, the intellectual property end and the subsequent flood of off-brand alternatives have considerably impacted income. This poses questions about the long-term sustainability of analogous me… Read More